Table 3: Summary of studies showing the efficacy of intermittent subcutaneous apomorphine injections in Parkinson’s disease patients[28],[29],[30],[31],[32],[33],[34],[35],[36]
![Table 3: Summary of studies showing the efficacy of intermittent subcutaneous apomorphine injections in Parkinson’s disease patients<sup>[28],[29],[30],[31],[32],[33],[34],[35],[36]</sup>](articles/2020/3/3/images/AnnMovDisord_2020_3_3_145_300254_t6.jpg)
| Close | |
|
|
|
|
Table 3: Summary of studies showing the efficacy of intermittent subcutaneous apomorphine injections in Parkinson’s disease patients[28],[29],[30],[31],[32],[33],[34],[35],[36]
|
|